59 Firmen

Acthera Therapeutics Ltd.

https://acthera-therapeutics.com/  

8952 Schlieren, Grabenstrasse 11a / R&D facility


 info@actheratx.com

ACTHERA is a Swiss biotech company and is the result of over 10 years of academic research & development in the universities of Basel, Fribourg and Texas Dallas (USA). The therapeutic platform is based on Hard-Shelled Liposomes (HSLs) that can contain a broad variety of therapeutically active ingredients. ACTHERA’s unique and highly innovative release mechanism will allow the release of active ingredients at therapeutic sites, thus revealing an extraordinarily wide field of applications to transform numerous therapeutic areas.

Acthera Therapeutics Ltd.

Grabenstrasse 11a

8952 Schlieren

Anjarium Biosciences AG

http://www.anjarium.com/  

8952 Schlieren, Wagistrasse 25

 +41 44 552 38 88
 info@anjarium.com

Anjarium Biosciences AG is a genetic medicines company focused on creating and delivering a new generation of targeted gene therapies to patients. Anjarium’s versatile platform builds on novel therapeutic payloads and delivery technologies, with the aim to unlock the full potential of gene therapy.

Anjarium Biosciences AG

Wagistrasse 25

8952 Schlieren

Artha AG

https://artha-x.com  

8952 Schlieren, Wagistrasse 21


 contact@artha-x.com

As a team of experienced phycisists and software engineers, we aim to provide integrated solutions harnessing the potential of seamless software-hardware integration into systems where they can be applied in a product to gain the best access to information. This data is then visualized for best use and customer benefit.

Artha AG

Wagistrasse 21

8952 Schlieren

Athebio AG

https://www.athebio.com/  

8952 Schlieren, Grabenstrasse 11a

  +41 44 508 08 28
 hello@athebio.com

Athebio develops advanced binding molecules based on repeat proteins to help drug developers fill their pipelines with innovative drug candidates.

Athebio AG

Grabenstrasse 11a

8952 Schlieren

Bio-Technopark Schlieren-Zürich

http://www.bio-technopark.ch/  

8952 Schlieren, Wagistrasse 23

 +41 76 336 99 44
 mario.jenni@bio-technopark.ch

The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.

Bio-Technopark Schlieren-Zürich

Wagistrasse 23

8952 Schlieren

BiognoSYS AG

http://www.biognosys.ch/  

8952 Schlieren, Wagistrasse 25

 +41 44 738 20 40
 info@biognosys.ch

BiognoSYS provides proteomics solutions to scientists and clinicians.

BiognoSYS AG

Wagistrasse 25

8952 Schlieren

CDR-Life AG

http://cdr-life.com/  

8952 Schlieren, Wagistrasse 14


 konstantin.vonschulthess@cdr-life.com

CDR-Life is a Zurich-based biotech company that discovers and develops innovative medicines for the treatment of high need diseases. We invent and develop therapeutic antibody fragments with a focus on immuno-oncology and ophthalmology.

CDR-Life AG

Wagistrasse 14

8952 Schlieren

Cellerys AG

http://www.cellerys.com/  

8952 Schlieren, Wagistrasse 21

Cellerys is a spin-off from University Hospital and University of Zurich. The company develops new therapies against Multiple Sclerosis (MS).

Cellerys AG

Wagistrasse 21

8952 Schlieren

Crystallise! AG

http://www.crystallise.ch  

8952 Schlieren, Grabenstrasse 11a

 +41 44 558 34 00
 info@crystallise.ch

Crystallise! operates an independent lab for crystallographic services (X-ray diffraction of single crystals) focussing on identifications of small molecule substances including air/moisture/temperature sensitive compounds and unique analyses of liquids.

Crystallise! AG

Grabenstrasse 11a

8952 Schlieren

CUTISS AG

http://cutiss.swiss  

8952 Schlieren, Wagistrasse 27

 +41 43 549 21 12
 info@cutiss.swiss

After more than 15 years of research (Tissue Biology Research Unit, University Children’s Hospital Zurich), CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDA Orphan drug designation for the treatment of burns.

CUTISS AG

Wagistrasse 27

8952 Schlieren

Mehr Ergebnisse

Nach oben